[144] Dynatrace, Inc. SEC Filing

Rhea-AI Filing Summary

Dynatrace, Inc. (DT) Form 144 notifies a proposed sale of 7,506 shares of common stock through Morgan Stanley Smith Barney LLC with an aggregate market value of $373,306.41, and an approximate sale date of 09/09/2025. The filing lists 301,506,242 shares outstanding. The shares to be sold were acquired on 09/05/2025 as 4,651 performance shares and 2,855 restricted stock. The filing also discloses a prior sale by Daniel J. Zugelder of 15,822 shares on 07/01/2025 for $867,702.21. The filer certifies they are not aware of any undisclosed material adverse information about the issuer.

Positive

• Transaction disclosed under Rule 144, indicating regulatory compliance

Negative

• None.

Insights

Securities Analyst

TL;DR Routine insider notice of proposed sale; disclosed acquisition dates and a recent larger sale are provided.

The Form 144 details a small proposed disposition relative to the issuer's outstanding shares: 7,506 shares versus 301,506,242 outstanding. The filing records that the securities were awarded on 09/05/2025 as performance shares and restricted stock, indicating these are insider compensation-related disposals rather than open-market purchases. The filing also reports a prior sale of 15,822 shares on 07/01/2025 for $867,702.21, which is documented for aggregation purposes. Overall this is a compliance disclosure under Rule 144 without standalone financial metrics or forward-looking statements.

Corporate Governance Expert

TL;DR Compliance-focused disclosure showing insider sales tied to compensation vesting; no material nonpublic information asserted.

The notice includes required representations about material information and references possible reliance on trading plans. The timing—acquisition on 09/05/2025 and proposed sale on 09/09/2025—suggests vesting-triggered sales. Disclosure of the broker and exact aggregate market value meets regulatory transparency expectations. There are no allegations or indicators of governance issues in the text; the form is procedural and aimed at regulatory compliance.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7506	373306.41	301506242	09/09/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/05/2025	Performance Shares	ISSUER			4651	09/05/2025	Not Applicable
Common	09/05/2025	Restricted Stock	ISSUER			2855	09/05/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
DANIEL J ZUGELDER 280 Congress Street, 11th Floor Boston MA 02210	Common	07/01/2025	15822	867702.21

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What securities does Dynatrace's Form 144 (DT) propose to sell?

The filing proposes sale of 7,506 common shares of Dynatrace.

When is the proposed sale date listed on the Form 144 for DT?

The approximate date of sale is listed as 09/09/2025.

What is the aggregate market value and who is the broker on the Form 144?

The aggregate market value is $373,306.41 and the broker is Morgan Stanley Smith Barney LLC.

How many shares outstanding does the filing state for Dynatrace?

The filing reports 301,506,242 shares outstanding.

Were the shares being sold recently acquired and how?

Yes; the shares were acquired on 09/05/2025 as 4,651 performance shares and 2,855 restricted stock.

Does the Form 144 disclose any prior sales by the same person?

Yes; it discloses that Daniel J. Zugelder sold 15,822 shares on 07/01/2025 for $867,702.21.